BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
US Army
McKesson
Cantor Fitzgerald
Merck
McKinsey
Novartis
Argus Health
Chinese Patent Office
Cerilliant

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,241,243

« Back to Dashboard

Summary for Patent: 8,241,243
Title:Needleless injector drug capsule and a method for filling thereof
Abstract: A method for filling needleless injector capsules with liquid drug, whereby dissolved gas within the drug is replaced by a less soluble gas in order to reduce the inclusion of gas bubbles, or to prevent the growth of bubbles during storage and thereby prevent breakage of the capsules.
Inventor(s): William; Henry (Cambridge, GB), Andrew; Lewis (Cambridge, GB)
Assignee: Zogenix, Inc. (Emeryville, CA)
Application Number:10/496,357
Patent Claim Types:
see list of patent claims
Formulation; Dosage form;

Drugs Protected by US Patent 8,241,243

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-001 Jul 15, 2009 BX RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,241,243

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0127942.1Nov 21, 2001
PCT Information
PCT FiledNovember 21, 2002PCT Application Number:PCT/GB02/05220
PCT Publication Date:June 05, 2003PCT Publication Number: WO03/045479

Non-Orange Book US Patents Family Members for Patent 8,241,243

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,118,771 Needleless injector drug capsule and a method for filling thereof ➤ Subscribe
8,241,244 Needleless injector drug capsule and a method for filling thereof ➤ Subscribe
8,491,524 Needleless injector drug capsule and a method for filling thereof ➤ Subscribe
8,663,158 Needleless injector drug capsule and a method for filling thereof ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,241,243

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan 4351056 ➤ Subscribe
Japan 2005510307 ➤ Subscribe
United Kingdom 0127942 ➤ Subscribe
European Patent Office 1446177 ➤ Subscribe
Germany 60220701 ➤ Subscribe
Canada 2468283 ➤ Subscribe
Australia 2002343045 ➤ Subscribe
Austria 364417 ➤ Subscribe
World Intellectual Property Organization (WIPO) 03045479 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Cipla
Healthtrust
Queensland Health
Moodys
Julphar
Cerilliant
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot